Ioana Lancranjan - Concepedia

Author

Ioana Lancranjan

Sanden (Japan)

Also Known As

I Lancranjan, I. LANCRANJAN, I. Lancranjan, IOANA LANCRANJAN, Ioana Lancranjan, Lancranjan, I, I

Publications

Citations

H-Index

Concepts

All Affiliations

Sanden (Japan)Novartis (Switzerland)University of Oslo University of Naples Federico II Queen Elizabeth Hospital Birmingham

About

Ioana Lancranjan is an author at Sanden (Japan) specializing in medicine, endocrinology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	26	1.9K
2	Public Health	8	8	809
3	Engineering	1	1	107
4	Health Sciences	1	1	33
5	Social Sciences	1	1	14

Ioana Lancranjan

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Reproductive Ability of Workmen Occupationally Exposed to Lead Ioana Lancranjan, Horia I. Popescu, Olimpia Găvănescu, Archives of Environmental Health An International Journal Occupational ToxicologyEndocrine DisruptorsInfertilityAndrologyReproductive Ability	1975	463
Long-Term Effects of Depot Long-Acting Somatostatin Analog Octreotide on Hormone Levels and Tumor Mass in Acromegaly<sup>1</sup> Annamaria Colao, Diego Ferone, Paolo Marzullo, The Journal of Clinical Endocrinology & Metabolism	2001	258
Sandostatin LAR in Acromegalic Patients: Long Term Treatment A K Fløgstad, Johan Halse, S. J. Bakke, The Journal of Clinical Endocrinology & Metabolism ThrombosisTranslational MedicineSandostatin LarGrowth HormoneThyroid Function	1997	176
Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly. Paul M. Stewart, K F Kane, Shona Stewart, The Journal of Clinical Endocrinology & Metabolism Growth HormoneMedicineImmunologyEffective TreatmentIm Injections	1995	154
A Pregnancy in an Acromegalic Woman during Bromocriptine Treatment: Effects on Growth Hormone and Prolactin in the Maternal, Fetal, and Amniotic Compartments* Mario Bigazzi, R. Ronga, Ioana Lancranjan, The Journal of Clinical Endocrinology & Metabolism Fetal PituitaryFertilityBromocriptine TherapyReproductive HealthGynecology	1979	152
Sandostatin® LAR®: A promising therapeutic tool in the management of acromegalic patients Ioana Lancranjan, Christian Bruns, P Jaquet, Metabolism Translational MedicineAcromegalic PatientsSandostatin® Lar®PharmacologyPromising Therapeutic Tool	1996	148
Long‐term therapy with long‐acting octreotide (Sandostatin‐LAR<sup>®</sup>) for the management of acromegaly P.H. O'Connor Davies, Susan E. Stewart, Ioana Lancranjan, Clinical Endocrinology	1998	139
Cardiovascular Effects of Depot Long-Acting Somatostatin Analog Sandostatin LAR in Acromegaly* Annamaria Colao, Paolo Marzullo, Diego Ferone, The Journal of Clinical Endocrinology & Metabolism	2000	126
Parenteral depot-systems on the basis of biodegradable polyesters Thomas Kissel, Zdenêk Brich, S. Bantle, Journal of Controlled Release EngineeringDegradable PlasticParenteral Depot-systemsPolymer ScienceBiodegradable Polymers	1991	107
Effect of dopamine agonist medication on prolactin producing pituitary adenomas Kálmán Kovács, Lucia Ştefăneanu, Éva Horváth, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin Pituitary GlandEndocrine MechanismDopamine Agonist MedicationMedicineNeuroendocrine Mechanism	1991	98

Page 1